Ren Xu Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy

Professor

University of Arkansas for Medical Sciences

faculty

COM | Radiation Oncology

Research Areas

Links

Lab Website UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Ren Xu's research focuses on advancing cancer treatment methodologies, particularly through the application of radiation therapy. As a Professor in Radiation Oncology at the University of Arkansas for Medical Sciences, Xu investigates mechanisms to improve the efficacy and safety of cancer treatments. Their work involves exploring novel approaches to target cancer cells while minimizing damage to healthy tissues, a critical challenge in oncology.

Xu's laboratory is actively engaged in research that aims to understand the complex biological responses to cancer and its treatment. This includes investigating molecular pathways involved in tumor growth, progression, and response to therapy. The research endeavors to translate fundamental scientific discoveries into clinical applications, ultimately seeking to improve outcomes for patients diagnosed with various forms of cancer. The lab's active website suggests a commitment to disseminating research findings and engaging with the broader scientific community.

ARA Academy 2025 Innovation Scholar

Dr. Xu is a newly appointed division director at the UAMS Cancer Institute. Previously a tenured professor of pharmacology at the University of Kentucky's Markey Cancer Center, his research focuses on microenvironmental cues and their modulation of breast cancer progression, with emphasis on identifying strategies to inhibit breast cancer metastasis and drug resistance. Several junior faculty he mentored have secured NIH R01 and foundation grants. His research has been continuously supported by multiple NCI R01 grants.

Policy Impact

Brings continuous NCI R01 grant funding and cancer research leadership to Arkansas, strengthening UAMS's capacity to compete for federal biomedical research dollars.